Archive for March, 2006封存2006年3月

How To Live With Diabetes如何生活与糖尿病

Friday, March 31st, 2006 周五, 2006年3月31日

Research shows that the number of diabetic patients has increased twofold in the last 20 years.研究表明,有多少糖尿病患者已增加了两倍,在过去20年。 The only solution for fighting diabetes is to be conscious about the disease.唯一的解决方法,争取糖尿病是要意识到这种疾病。

Diabetes Vaccine Is Currently In A Phase II Trial糖尿病疫苗目前正处于二期试验

Friday, March 31st, 2006 周五, 2006年3月31日

The first Seattle-Sweden Childhood Diabetes Awareness Day in Seattle, Washington is being organized by Professor Åke Lernmark who works at the University of Washington and the Consulate General of Sweden in LA, on 1st April.第一次在西雅图的瑞典儿童糖尿病的认识,天在美国华盛顿州西雅图,现正举办的教授åke lernmark谁工程在华盛顿大学和总领事馆,瑞典在La ,对4月1日。 The symposium will feature presentations by researchers from Sweden and Seattle.专题讨论会的功能介绍,研究人员从瑞典和西雅图等城市。 Speakers include Professor Carl David Agardh of Malmö’s University [...]讲者包括教授卡尔大卫agardh的马尔默的大学[ … … ]

Are You at Risk of Diabetes?你是在患糖尿病的危险呢?

Friday, March 31st, 2006 周五, 2006年3月31日

To check the growing cases of Diabetes, New York Mayor Michael R Bloomberg launched the American Diabetes Association’s (ADA) ad campaign “Are You at Risk?”, a nationwide summon to identify millions of Americans who are unaware of this disease.检查日益增长的案件糖尿病,纽约市长迈克尔彭博推出r美国糖尿病协会( ADA )的广告系列“你是在风险? ” ,在全国范围内传召找出以百万计的美国人谁都不知道这种疾病。

End of Line for INGAP?生产线后端为的InGaP ?

Thursday, March 30th, 2006 周四, 2006年3月30日

There was lots of excitement and hope over Phase 2 trial of INGAP.有很多的兴奋和希望超过第2阶段试验的InGaP 。 At one time the positive results were coming in even though one of the participants, I personally know, complained of not benefitting from the trial.在同一时间的积极成果,分别在未来即使其中一名参与者,我个人知道,抱怨没有受惠,从审判。 We thought he could be part of control group.我们以为他可以的一部分,对照组。 The final result of Phase 2 trial is [...]最后的结果,第2阶段试验是[ … … ]

Quigley Files IND Application to FDA for Diabetic Neuropathy Drug奎格利档案ind应用林业局为糖尿病神经病变的药物

Wednesday, March 29th, 2006 周三, 2006年3月29日

The Quigley Corporation has filed an application with the FDA to begin clinical trials of QR-333 for the treatment of diabetic peripheral neuropathy.奎格利该公司已提交了申请与FDA开始临床试验的QR - 333 ,为治疗糖尿病周围神经病变。

Researchers Reverse Juvenile Diabetes in Mouse - FDA Approves Clinical Trial研究人员反向少年糖尿病的小鼠-F DA批准临床试验

Wednesday, March 29th, 2006 周三, 2006年3月29日

Researcher Massimo Trucco at Children’s Hospital of Pittsburgh have observed marked amelioration of diabetes in a mouse model by a novel treatment strategy involving specific modification of the animal’s own dendritic cells, thereby reversing diabetes in animal studies.研究员马西莫trucco在儿童医院的匹兹堡观察,显着改善糖尿病的小鼠模型是由一种新的治疗策略,涉及具体的改进动物自身的树突状细胞,从而扭转了糖尿病,在动物研究中。

Pre-Diabetes Can be Detected and Cured前糖尿病可以查出和治愈

Wednesday, March 29th, 2006 周三, 2006年3月29日

Before people develop Type2 Diabetes, they almost always have Pre-Diabetes a condition where blood glucose levels are higher than normal but not high enough to be diagnosed as Diabetes.之前,人民发展2型糖尿病,他们几乎总是有前糖尿病的条件,如血糖水平高于正常,但不够高,无法被诊断为糖尿病。

Diabetes Linked to Pancreatic Cancer Risk糖尿病联系在一起的胰腺癌危险

Wednesday, March 29th, 2006 周三, 2006年3月29日

High insulin levels and increased resistance to the hormone are found to be associated with a higher risk of pancreatic cancer.高胰岛素水平,并增加抗激素被发现要与之关联的更高的患胰腺癌的危险。 A healthy diet and lifestyle may help to reduce the risk of it.健康的饮食习惯和生活方式,可能有助于减少风险。

Peripheral Artery Disease Increases the Risk of Diabetes周围动脉疾病,增加患糖尿病的危险

Wednesday, March 29th, 2006 周三, 2006年3月29日

People with Peripheral Artery Disease or PAD (a condition where blood flow to the legs is reduced) and non-insulin dependent type 2 diabetes are more likely to die from heart related ailment.人与周围动脉疾病或垫(一条件的地方血流量至腿部,是减少)和非胰岛素依赖型2型糖尿病患者更容易死于心脏相关疾病。

Narrowing of Blood Vessels Can Begin During the IGT Stage of Diabetes.缩小血管就可以开始在糖耐量低减阶段的糖尿病。

Tuesday, March 28th, 2006 周二, 2006年3月28日

IGT (Insulin Glucose Tolerance) is a stage prior to the person becoming diabetic.糖耐量低减(胰岛素糖耐量)是一个阶段,之前的人成为糖尿病。 Patients with IGT often will have normal or only minimally elevated HbA1c values but frequently will have other features of metabolic or ‘insulin resistance’ syndrome, explaining the increasing risk of vascular disease.患者的糖耐量低减,往往将有正常的或仅微高架糖化血色素值,但经常会有其他的功能代谢或'胰岛素抵抗综合征,解释的风险越来越大血管疾病。